dCK expression and gene polymorphism with gemcitabine chemo-sensitivity in patients with pancreatic ductal adenocarcinoma

被引：0
|
作者：
Altaf, K. [1 ]
Xiong, J. [2 ]
Ke, N. [2 ]
Wang, Y. [2 ]
Liu, X. [2 ]
机构：
[1] NHS Fdn Trust, Warrington & Halton Hosp, Warrington, Cheshire, England
[2] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
来源：
BRITISH JOURNAL OF SURGERY | 2016年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
0418
引用
收藏
页码：36 / 37
页数：2
相关论文
共 50 条
  • [41] Quercetin improves pancreatic cancer chemo-sensitivity by regulating oxidative-inflammatory networks
    Hu, Yaoyuan
    Li, Rui
    Jin, Junyi
    Wang, Yihui
    Ma, Rui
    JOURNAL OF FOOD BIOCHEMISTRY, 2022, 46 (12)
  • [42] A gene expression signature for predicting response to neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma
    Nishiwada, Satoshi
    Sho, Masayuki
    Cui, Ya
    Yamamura, Kensuke
    Akahori, Takahiro
    Nakagawa, Kenji
    Nagai, Minako
    Nakamura, Kota
    Takagi, Tadataka
    Ikeda, Naoya
    Li, Wei
    Baba, Hideo
    Goel, Ajay
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (03) : 769 - 779
  • [43] Pancreatic ductal adenocarcinoma in young patients
    Pernick, NL
    Eldean, ZS
    Kabbani, W
    Philip, P
    Shields, A
    Vaitkevicius, V
    Adsay, NV
    MODERN PATHOLOGY, 2001, 14 (01) : 201A - 201A
  • [44] Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma
    Li Wang
    Huanwen Wu
    Lili Wang
    Junliang Lu
    Huanli Duan
    Xuguang Liu
    Zhiyong Liang
    Diagnostic Pathology, 11
  • [45] TWIST2 gene expression predicts for chemo-sensitivity in patients from two randomized trials of adjuvant FAC/FEC.
    Tomasic, G
    Scott, V
    Conforti, R
    Michiels, S
    Andre, F
    Ahomadegbe, JC
    Koscielny, S
    Spielmann, M
    d'Assignies, MS
    Garbay, JR
    Feunteun, J
    Lazar, V
    Vassal, G
    Tursz, T
    Arriagada, R
    Delaloge, S
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S47 - S48
  • [46] Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma
    Wang, Li
    Wu, Huanwen
    Wang, Lili
    Lu, Junliang
    Duan, Huanli
    Liu, Xuguang
    Liang, Zhiyong
    DIAGNOSTIC PATHOLOGY, 2016, 11
  • [47] Effect of Y-chromosome Gene Expression on Pancreatic Ductal Adenocarcinoma Progression
    Kawakubo, K.
    Von Alt, K. N.
    Hank, T.
    Mino-Kenudson, M.
    Lillemoe, K. D.
    Warshaw, A. L.
    Fernandez-del Castillo, C.
    Liss, A. S.
    PANCREAS, 2019, 48 (10) : 1460 - 1460
  • [48] Immune-mediated cystatin A expression in patients with pancreatic ductal adenocarcinoma
    Komura, T.
    Sakai, Y.
    Takabatake, H.
    Harada, K.
    Ohta, T.
    Kitagawa, H.
    Kaneko, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] Prognostic gene signature for pancreatic ductal adenocarcinoma
    Yeh, J.
    Bentrem, D. J.
    Routh, E. D.
    Fan, C.
    Melstrom, L. G.
    Talamonti, M. S.
    Perou, C. M.
    Der, C. J.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 2 - 3
  • [50] Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes
    Zhao, Lan
    Zhao, Hongya
    Yan, Hong
    BMC CANCER, 2018, 18
12345